Press Releases

TALLC in the News

July 7, 2020

TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001

June 3rd, 2020

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

CONTACT US

Phone: 514 883 3447

Email: info@tallcinc.com

NEWS

TALLC Corporation Announces Grant of New SmartCelle Patent for
Enhanced Ocular Delivery of TA-A001

Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001

TALLC Innovation in Vision

© TALLC Inc. 2020